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SULFOMUCOPOLYSACCHARIDES IN BRAINI
Although mucopolysaccharides have been shown to be present in brain
by histological techniques,"' few attempts have been made to characterize
these substances, and only Brante' has described the presence in brain of
a sulfomucopolysaccharide. The highly acidic sulfomucopolysaccharides
(SMPS) may be important in contributing to the pool of anionic sub-
stances, as yet not fully accounted for, that preserve electroneutrality in
brain,' and in addition they may function in the binding of biogenic amines
and in the transport of solutes.! The importance of SMPS in neural dis-
orders is indicated by their accumulation in gargoylism (Hurler-Pfaundler's
syndrome)6 and their possible role in familial myoclonic epilepsy7 and in
some encephalopathies' in which substances accumulate that have histo-
chemical properties consonant with SMPS.
These observations prompted us to study the regional, cellular, and
subcellular distribution of SMPS in brain, and these findings are pre-
sented here. Also included is a description of some chemical and chroma-
tographic properties of the SMPS and measurement of its turnover rate
in brain. A preliminary report of this work has appeared.!
METHODS
Extraction and fractionation procedures. Rats (150 g.) were injected intraperi-
toneally with 1 mc. of S'8-sulfate obtained from the Oak Ridge National Laboratories.
At stated time intervals the animals were decapitated and the organs removed,
weighed, and homogenized. SMPS were extracted by a method previously described,l'
consisting of digestion with pancreatin, dialysis, and precipitation with acetone.
Cerebroside sulfate (CS) was extracted by the method of Lees, et al.' Cells were
fractionated in 0.25 M sucrose."
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Autoradiography. Sixteen days after the intraperitoneal injection of 1 mc. of
S35-sulfate into a rat, the brain was removed and fixed in 10 per cent formalin
and treated as described by Bostrom and Odeblad.'8 Sections of 10 micra were mounted
in paraffin on glass slides and placed in contact with Kodak No Screen X-ray film
in a desiccator in the cold for 50 days, after which they were developed.
Analytical methods. The orcinol" and carbazole'5 reactions have been described.
Sulfate was measured by the method of Green and Robinson."' Taurine and cysteic
acid were shown by paper chromatography."7 Methods for showing metachromasia and
hydrolytic procedures have been described.10 Radioactivity on chromatograms was
measured directly with the aid of an end-window Geiger-Muller counter.
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FIG. 1. Turnover rates of S35-labeled sulfomucopolysaccharides (SMPS) and cere-
broside sulfate (CS) in brain after the injection of S35-sulfate.
The dialyzing membrane, used to prepare SMPS, was shown to release, even after
prior heating and washing, a non-dialyzable substance(s) which was precipitated
by the same reagents used to precipitate heparin; work in this laboratory has shown
that this, after hydrolysis, yielded a substance which reacted like inorganic sulfate.
Accordingly, it was necessary to correct for the contribution of this material to
the analytical results obtained with SMPS, and a control was run which consisted
of a dialysis bag of the same size and containing the same substances that were used
for the preparation of the SMPS, lacking only the tissue.
RESULTS
SMPS of brain. The crude S35-labeled extract of brain showed meta-
chromasia under the same conditions as did heparin,'0 i.e., it formed a
purple precipitate with Azure A. The carbazole-orcinol ratio was 0.73 and
the fraction contained 19 per cent ester-sulfate. Paper chromatography of
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the hydrolysates in a mixture of n-propanol-ethyl acetate-water (7:1:2)
showed two ninhydrin-positive spots; these spots, which also reacted with
alkaline silver nitrate, had the same RF values as those of glucosamine and
galactosamine.
Turnover rate of brain SMPS. In Figure 1, the turnover rates of
brain SMPS and brain CS are compared. More S35-sulfate was incor-
porated into SMPS than into CS. Brain SMPS turned over more rapidly
than brain CS (Fig. 1), but as shown in Table 1, less rapidly than the
TABLE 1. TURNOVER RATE AND HALF-LIFE (tO.5) OF S35-LABELED
SULFOMUCOPOLYSACCHARIDES IN VARIOUS ORGANS AND TISSUES OF
THE RAT AFTER INJECTION OF S35-SULFATE
Hours after injection
6 15 24
(cpm 1Ol/g wet weight) Organ
48
to.5
(hours)
Brain see Figure 1 150
Kidney 370 370 290 150 40
Lung 230 130 140 80 30
Spleen 260 190 130 100 24
Plasma 30 20 10 5 24
Perirenal fat 30 20 10 22
Small intestine 590 440 280 50 20
Stomach 670 450 190 100 18
Adrenal gland 210 110 110 30 18
Liver 230 110 30 20 15
Large intestine 960 460 230 150 12
SMPS in any other organ or tissue. From the decay curve, the estimated
half-life of SMPS in brain was 150 hours, significantly longer than
that of the SMPS in any other tissue examined.
Paper chromatography of SMPS. Paper chromatography was carried
out in two solvent systems (Table 2). In both systems, brain SMPS were
resolved into two radioactive, metachromatic spots. The RF values of brain
SMPS were different from those of CS: in the isopropanol-formate system,
CS ran with the solvent front (i.e., RF = 1.0) and in the diisobutylketone
system, CS had an RF of 0.50. When chromatographed in the latter
solvent, in admixture with CS, the RF values of brain SMPS were un-
changed and both SMPS spots (RF 0.00 and 0.30) were clearly separated
from CS (RF = 0.50).
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In the isopropanol-formate system, a significantly greater percentage
of immobile (RF 0.00) radioactive material was present in brain SMPS
than in the SMPS of other organs. In the diisobutylketone system, brain
SMPS showed a radioactive and metachromatic spot at RF 0.30, unlike
the SMPS of any other organ, which were immobile in this system.
Heparin extracted from neoplastic mast cells'0 also failed to migrate in
this system.
TABLE 2. PAPER CHROMATOGRAPHY OF S35-SULFOMUCOPOLYSACCHARIDES
Isopropanol: 0.04 M Diisobutylketone :acetic
ammnonium formate (35:65) acid:water (40:25:5)*
Per cent Per cent
Organ RFvalue radioactizity RF value radioactivity
Brain 0.00 25 0.00 50
0.80 75 0.30 50
Kidney 0.00 10 0.00 100
0.83 90
Large intestine 0.00 1 0.00 100
0.83 99
Small intestine 0.00 1 0.00 100
0.83 99
Liver 0.83 100 0.00 100
Adrenal gland 0.80 100 0.00 100
Cerebroside sulfate 1.00 100 0.50 100
*Paper coated with silicone or silicic acid.
Extraction of SMPS by lipid solvents. When aqueous brain S35-SMPS
were shaken with five volumes of a mixture of chloroform:methanol (2:1,
v/v), 50 per cent of the radioactivity appeared in the organic layer. When
shaken with three volumes of trichlorotrifluoro-ethane (CFCI2-CCIF2),
60 per cent of the radioactivity appeared in the organic layer. In con-
trast, none of the S35-SMPS of the other organs examined was extractable
into these solvents, nor was heparin from mast cells.'0 Paper chroma-
tography in the diisobutylketone system showed that the trichlorotrifluoro-
ethane extract ofbrain SMPS contained all the material with anR. of0.30,
and, in addition, some of the immobile material. The aqueous phase con-
tained only the immobile material.
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Subcellular distribution of SMPS. Twenty-four hours after injecting
S35-sulfate into a rat, the brain, kidney, and liver were removed, fraction-
ated, and the SMPS were extracted. Table 3 shows the distribution of
SMPS, as measured by radioactivity. The major portion of the labeled
SMPS was found in the microsomal fraction in brain, whereas in kidney
and liver the microsomal fractions contained less SMPS than did the
fraction sedimenting with cell nuclei and debris.
Autoradiography of brain after S35-sulfate injection. Autoradiograms
of rat brain taken 16 days after injecting S35-sulfate showed (Fig. 2) a
distinct localization of the isotope in the white matter. These contrasted
with autoradiograms of rat brain taken two days after the injection
of S35-sulfate which showed the isotope primarily in gray matter.
TABLE 3. INTRACELLULAR DISTRIBUTION OF SMPS IN BRAIN, KIDNEY,
AND LIVER OF THE RAT (PER CENT)
Fraction Brain Kidney Liver
Nuclei and debris 24 49 51
Mitochondria 6 7 6
Microsomes 38 24 30
Supernatant fraction 32 20 13
To gain some insight into the nature of the compounds responsible for
autoradiograms at these times, brains were fractionated at both two and
16 days after the injection of S35-sulfate, and all isotopic material was
accounted for.
Disposition of S35-sulfate in brain. At two days and 16 days after the
injection of S35-sulfate, brains were removed and homogenized with 20
volumes of a mixture of chloroform :methanol (2:1) and filtered. The
filtrate was washed with one-fifth its volume of water and the water-wash
was saved. The organic layer was evaporated in vacuo and suspended in
the original volume of chloroform:methanol and centrifuged. On paper
chromatography in the diisobutylketone system, the material that redis-
solved in chloroform :methanol showed a single radioactive spot at RF 0.50,
identical with purified CS.1 A small amount did not redissolve readily in
chloroform :methanol, and this was assumed to be a sulfur-containing
proteolipid.'9 The residue from the original chloroform:methanol extract
was shaken with 80 per cent aqueous ethanol, and this extract was com-
bined with the previously described water-wash; taurine and cysteic acid
were found in these extracts. The residue after alcohol extraction was then
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Upper lcft: frontal lobe; radioactivity is most heavily concelntrated in the olfactory
tracts.
Upper miiiddle: thalamus; radioactivity is most heavily concentrated in the corpus
callosum and secondarily in the white matter of the thalamus, caudate nucleus, anid
pyriform cortex (olfactory).
Ulpper right: radioactivity is heavily concenitrated in the initernal capsule and the
optic tracts.
Lower left: radioactivity is concenitrated in the lateral aspects of the brain stem, in
particular in a pathway identified as the lateral lemiscus.
LozcLer mliddle: radioactivity is greatest in the pyramidal tracts, the descendilng tract
of cranial nerve V, the restiformii body, and the white matter of thle cerebellulil.
Lozcer right: radioactivity is greatest in the pyramidal tracts, cranial nerve VII,
the restiform body, and the white matter of the cerebellum.Brain sulfomucopolysaccharides ROBINSON, GREEN
put in a dialysis bag with pancreatin and incubated for three days with
4 1. of water maintained at pH 8.0-8.4 by the addition of ammonia; the
external solution was changed five times. The dialyzable material was
concentrated in vacuo and labeled "trypsin-sensitive protein." The non-
dialyzable material was shown to be SMPS.
Table 4 shows that two days after injecting S35-sulfate, 85 per cent of the
isotope was present as SMPS and CS; the rest as taurine, cysteic acid, and
protein. At this time, SMPS showed twice as much radioactivity as CS.
However, 16 days after injection of the isotope, when all the isotopic
TABLE 4. DISPOSITION OF S35-SULFATE IN THE BRAIN OF RATS AT 2 DAYS AND
16 DAYS AFTER THE INTRAPERITONEAL INJECTION OF S35-SULFATE
Per cent
Fraction radioactivity
2days 16 days
SMPS 58 35
CS 29 65
Taurine and cysteic acid 6 0
Trypsin-sensitive protein 4 0
Proteolipid 3 0
material was either CS or SMPS, the radioactivity in CS was nearly twice
that in SMPS.
Lack of effect of cortisone. In view of observations that cortisone inhibits
the uptake of S85-sulfate into chondroitin sulfate," the effect of cortisone
on the incorporation of S35-sulfate into brain SMPS and brain CS was
measured. Intraperitoneal administration of 10 mg. of cortisone per day
for six days, a regimen which killed three out of eight rats, had no effect
on the uptake of S35-sulfate into either the SMPS or CS of rat brain.
DISCUSSION
The SMPS of brain. SMPS extracted from brain contained glucosamine
and galactosamine, had 19 per cent ester-sulfate and a carbazole-orcinol
(C/G) ratio of 0.73. The sulfate values were similar to those of chondroitin
sulfates A, B, and Ce" and of heparitin sulfate.' But the C/O values of
the brain SMPS were different from those of chondroitin sulfates A, B, C
and heparitin sulfate, which are, respectively, 1.5, 0.46, 1.8, and about 2.
The SMPS of the brain may be different from any of these, or it may be a
mixture of two or more of these. The sulfate and C/0 values on the
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SMPS extracted from rat brain are consistent with its being a mixture
of chondroitin sulfate B and heparitin sulfate, although undue emphasis
should not be placed on the C/O values since the presence of other orcinol-
reacting sugars in the extract, e.g., in gangliosides, would reduce this
ratio. However, it is unlikely that the SMPS described here is simply
such a mixture, since one of the components of the SMPS has lipoidal
properties, indicated both by its behavior on paper chromatography and
its extractability into lipid solvents.
The liposulfomucopolysaccharide could be detected in no other organ
except the brain (Table 2). Other experiments have ruled out the pos-
sibility that the liposulfomucopolysaccharide is an artifact arising from
complex-formation between a water-soluble SMPS and a brain lipid.18
Brain SMPS differed from the SMPS of other organs also in its rela-
tively slow turnover rate (Table 1). CS also turns over more slowly in
brain than in other organs.1
Subcellular distribution of SMPS. Another difference between the SMPS
of brain and those of kidney and liver was its subcellular distribution
(Table 3). In brain more SMPS was found in the microsomal and
supernatant fractions than in other portions of the cell; in kidney and liver,
more SMPS was found in the large particulate material (Table 3), as
was the heparin of neoplastic mast cells.0' It would thus appear that the
bulk of the SMPS in brain is not associated with mast cells, a conclusion
that agrees with histological observations showing a relative sparseness
of mast cells in the central nervous system.' It is of some interest that
laboratory findings by one of the authors shows that in both brain and
mast cells,2' histamine is found in the same subcellular fractions as are the
SMPS.
Regional and cellular localization of SMPS. The localization of SMPS
in brain may be deduced from a comparison of the autoradiograms made
16 days after the injection of S35-sulfate (Fig. 2) with those made two
days after such injection,'8 together with an examination of the disposition
of the S35-sulfate at these times (Table 4). At 16 days S35-sulfate was
found only in white matter (Fig. 2), at two days primarily in gray
matter.3'" All radioactivity at 16 days was in the form of CS and SMPS,
with twice as much in CS as in SMPS (Table 4 and Fig. 1). It is known
that CS is found primarily, perhaps exclusively, in white matter.' Moreover,
the slower turnover of CS than of SMPS (Fig. 1) paralleled autoradio-
graphic evidence obtained in mice' which showed S35-sulfate turns over
more slowly in white than in gray matter; this agrees with the conclusion
that autoradiograms at 16 days reflected localization of CS in white matter.
254
Volume 35, December 1962Brain sulfomucopolysaccharides ROBINSON, GREEN
Two days after the injection of S35-sulfate, the isotope was localized
primarily in the choroid plexus and in the gray matter: in the cerebrum,
especially in a layer consisting of polymorphous and fusiform cells; in
the cerebellum, especially in the granular layer and also in the molecular
layer and Purkinje cells.' At this time, almost twice as much radioactivity
was found in SMPS as in CS (Table 4, Fig. 1); exceedingly small amounts
were present as taurine and cysteic acid and as protein.
The most reasonable conclusion is that the two-day autoradiograms,
which show the isotope in grey matter, depict the localization of SMPS.
Several observations support this conclusion: first, the isotope is found
preponderantly as SMPS (Table 4); second, the more rapid turnover of
SMPS than of CS (Fig. 2) paralleled autoradiographic observations that
S35-sulfate turns over more rapidly in gray than in white matter;,"
and third, in gargoylism, a compound that migrates in the same manner as
does chondroitin sulfate was found primarily, perhaps totally, in gray
matter. It is also pertinent that those areas of the cerebellar cortex, which
showed localization of S35-sulfate two days after injection of the isotop6`
also showed metachromasiae and a positive periodic acid-Schiff (PA-S)
reaction;"' the results of these tests, although not based on specific
methods, are consistent with the presence of SMPS in these areas. Indeed,
the accumulation of S35-sulfate in brain roughly paralleled the intensity of
PA-S staining' and, in some areas, that of metachromasia." The SMPS
are probably synthesized by the neural cells rather than arising from
mast cells or connective tissue, for neither the distribution of mast cells'
nor the distribution of vasculart" or intervascular connective tissue' cor-
responded with that of SMPS.
Similarities between SMPS and gangliosides are worth noting. Like
SMPS, gangliosides are present in gray matter,' probably in the granular
layer of the cerebellar cortex,' and in microsomes;" gangliosides also con-
tain hexosamine," are metachromatic,7 and accumlate in gargoylism.6`"
SUMMARY
After the administration of S35-sulfate to rats and extraction of the
excised brain, a crude radioactive, non-dialyzable, acetone-precipitable
extract with properties of a sulfomucopolysaccharide (SMPS) was ob-
tained: it showed metachromasia, reacted with the carbazole reagent to
give a carbazole-orcinol ratio of 0.73, contained 19 per cent ester-sulfate,
and after hydrolysis was shown to contain glucosamine and galactosamine.
By paper chromatography the crude SMPS extract could be separated
into two radioactive and metachromatic spots, each distinct from cere-
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broside sulfate (CS). One of these fractions had solubility and paper
chromatographic properties consistent with those of a lipid. This differed
from the SMPS of other organs (and from CS) also in its intracellular
distribution and in its turnover rate. Autoradiography, in conjunction with
measurements of the disposition of injected S35-sulfate in brain, showed
that brain SMPS are found ingray matter.
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